• Something wrong with this record ?

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

R. Stein, G. Bogaert, HS. Dogan, L. Hoen, R. Kocvara, RJM. Nijman, J. Quaedackers, YF. Rawashdeh, MS. Silay, S. Tekgul, C. Radmayr,

. 2020 ; 39 (2) : 498-506. [pub] 20191203

Language English Country United States

Document type Guideline, Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc20025250

BACKGROUND: Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimes-even in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. MATERIAL & METHODS: After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update. RESULTS: In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option. CONCLUSION: In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025250
003      
CZ-PrNML
005      
20201222155130.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/nau.24248 $2 doi
035    __
$a (PubMed)31794087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Stein, Raimund $u Department of Pediatric, Adolescent and Reconstructive Urology, Medical Faculty Mannheim, University of Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
245    10
$a EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management / $c R. Stein, G. Bogaert, HS. Dogan, L. Hoen, R. Kocvara, RJM. Nijman, J. Quaedackers, YF. Rawashdeh, MS. Silay, S. Tekgul, C. Radmayr,
520    9_
$a BACKGROUND: Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimes-even in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. MATERIAL & METHODS: After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update. RESULTS: In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option. CONCLUSION: In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a neurogenní močový měchýř $x chirurgie $x terapie $7 D001750
650    _2
$a diverze moči $x metody $7 D014547
650    _2
$a urologické chirurgické výkony $x metody $7 D013520
655    _2
$a směrnice $7 D016431
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bogaert, Guy $u Department of Urology, University of Leuven, Belgium.
700    1_
$a Dogan, Hasan S $u Division of Pediatric Urology, Department of Urology, Hacettepe University, Ankara, Turkey.
700    1_
$a Hoen, Lisette $u Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Kocvara, Radim $u Department of Urology, First Faculty of Medicine in Praha, General Teaching Hospital, Charles University, Prague, Czech Republic.
700    1_
$a Nijman, Rien J M $u Department of Urology and Pediatric Urology, University Medical Centre Groningen, Rijks Universiteit Groningen, Groningen, The Netherlands.
700    1_
$a Quaedackers, Josine $u Department of Urology and Pediatric Urology, University Medical Centre Groningen, Rijks Universiteit Groningen, Groningen, The Netherlands.
700    1_
$a Rawashdeh, Yazan F $u Department of Urology, Aarhus, Denmark.
700    1_
$a Silay, Mesrur S $u Division of Pediatric Urology, Department of Urology, Istanbul Medeniyet University, Istanbul, Turkey.
700    1_
$a Tekgul, Serdar $u Division of Pediatric Urology, Department of Urology, Hacettepe University, Ankara, Turkey.
700    1_
$a Radmayr, Christian $u Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
773    0_
$w MED00003515 $t Neurourology and urodynamics $x 1520-6777 $g Roč. 39, č. 2 (2020), s. 498-506
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31794087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155126 $b ABA008
999    __
$a ok $b bmc $g 1599395 $s 1115936
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 39 $c 2 $d 498-506 $e 20191203 $i 1520-6777 $m Neurourology and urodynamics $n Neurol. urodyn. (Print) $x MED00003515
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options